Literature DB >> 29808268

[Bruton tyrosine kinase inhibition in dermatology and allergology].

B Wedi1.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 29808268     DOI： 10.1007/s00105-018-4190-x

Source DB:  PubMed          Journal:  Hautarzt        ISSN： 0017-8470            Impact factor:   0.751


× No keyword cloud information.
  8 in total

1.  Bruton tyrosine kinase inhibition: Clinical relevance beyond B cells.

Authors:  Balaji Banoth; Suzanne L Cassel
Journal:  J Allergy Clin Immunol       Date:  2017-04-26       Impact factor: 10.793

2.  Human NACHT, LRR, and PYD domain-containing protein 3 (NLRP3) inflammasome activity is regulated by and potentially targetable through Bruton tyrosine kinase.

Authors:  Xiao Liu; Tica Pichulik; Olaf-Oliver Wolz; Truong-Minh Dang; Andrea Stutz; Carly Dillen; Magno Delmiro Garcia; Helene Kraus; Sabine Dickhöfer; Ellen Daiber; Lisa Münzenmayer; Silke Wahl; Nikolaus Rieber; Jasmin Kümmerle-Deschner; Amir Yazdi; Mirita Franz-Wachtel; Boris Macek; Markus Radsak; Sebastian Vogel; Berit Schulte; Juliane Sarah Walz; Dominik Hartl; Eicke Latz; Stephan Stilgenbauer; Bodo Grimbacher; Lloyd Miller; Cornelia Brunner; Christiane Wolz; Alexander N R Weber
Journal:  J Allergy Clin Immunol       Date:  2017-02-16       Impact factor: 10.793

Review 3.  Role of mast cells and basophils in pruritus.

Authors:  Martin Steinhoff; Jörg Buddenkotte; Ethan A Lerner
Journal:  Immunol Rev       Date:  2018-03       Impact factor: 12.988

Review 4.  Systematic review of infectious events with the Bruton tyrosine kinase inhibitor ibrutinib in the treatment of hematologic malignancies.

Authors:  Benjamin F Tillman; James M Pauff; Gowri Satyanarayana; Mahsa Talbott; Jeremy L Warner
Journal:  Eur J Haematol       Date:  2018-02-06       Impact factor: 2.997

5.  KIT-D816V-independent oncogenic signaling in neoplastic cells in systemic mastocytosis: role of Lyn and Btk activation and disruption by dasatinib and bosutinib.

Authors:  Karoline V Gleixner; Matthias Mayerhofer; Sabine Cerny-Reiterer; Gregor Hörmann; Uwe Rix; Keiryn L Bennett; Emir Hadzijusufovic; Renata A Meyer; Winfried F Pickl; Jason Gotlib; Hans-Peter Horny; Andreas Reiter; Gerlinde Mitterbauer-Hohendanner; Giulio Superti-Furga; Peter Valent
Journal:  Blood       Date:  2011-06-16       Impact factor: 22.113

Review 6.  Basophils and skin disorders.

Authors:  Francesco Borriello; Francescopaolo Granata; Gianni Marone
Journal:  J Invest Dermatol       Date:  2014-02-06       Impact factor: 8.551

Review 7.  Bruton's Tyrosine Kinase: An Emerging Key Player in Innate Immunity.

Authors:  Alexander N R Weber; Zsofia Bittner; Xiao Liu; Truong-Minh Dang; Markus Philipp Radsak; Cornelia Brunner
Journal:  Front Immunol       Date:  2017-11-08       Impact factor: 7.561

Review 8.  Role of Bruton's tyrosine kinase in B cells and malignancies.

Authors:  Simar Pal Singh; Floris Dammeijer; Rudi W Hendriks
Journal:  Mol Cancer       Date:  2018-02-19       Impact factor: 27.401
  8 in total
  1 in total

Review 1.  Targeted Therapy for Chronıc Spontaneous Urtıcarıa: Ratıonale and Recent Progress.

Authors:  Ana M Giménez-Arnau; Andaç Salman
Journal:  Drugs       Date:  2020-11       Impact factor: 9.546
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.